Analysis of SKOV3 cells shows that low Brn-3b levels in untreated cells is significantly increased in response to drug treatment particularly when using the combination of cisplatin and paclitaxel, commonly used for treatment of patients with ovarian cancers. Here, POU4F2 is linked to ovarian cancer.